Beacon Pharmaceuticals Ltd. announced earnings results for the second quarter ended December 31, 2020. For the second quarter, the company announced sales was BDT 2,183.576 million compared to BDT 1,487.823 million a year ago. Operating income was BDT 382.080 million compared to BDT 82.280 million a year ago. Net income was BDT 234.418 million compared to BDT 27.228 million a year ago. Basic earnings per share from continuing operations was BDT 1.01 compared to BDT 0.12 a year ago. For the half year, sales was BDT 3,730.620 million compared to BDT 2,828.290 million a year ago. Operating income was BDT 507.473 million compared to BDT 250.084 million a year ago. Net income was BDT 290.995 million compared to BDT 68.824 million a year ago. Basic earnings per share from continuing operations was BDT 1.26 compared to BDT 0.3 a year ago.